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Desmoid tumors (DTs) are neoplasms of ﬁbroblastic origin characterized by lack of a capsule. They are nonmetastatic and locally
aggressive. Intraabdominal DTs are often observed in familial adenomatous polyposis and Gardner syndrome or subsequent to
localized traumatic injury. Sporadic forms are deﬁned as nontrauma- or nongenetic-related DTs. Isolated, sporadic pancreatic
DTs have been considered anecdotal, with only 9 cases described in the literature. We report the case of a 68-year-old man with a
caseofsporadiccysticDTlocalizedtothepancreatictail.Thetumorwasdiscoveredincidentallyduringcomputerizedtomography
performed for an unrelated condition. The patient was asymptomatic; however, biopsy was performed on the clinical suspicion
of cystic cancer of the pancreas. Pathology analysis showed ﬁbroblastic proliferation, and the diagnosis of DT was conﬁrmed by
immunohistochemical staining for beta-catenin. The patient underwent resection with no further treatment and remain disease-
free 60 months after surgery.
1.Background
Desmoid tumors (DTs); also known as aggressive ﬁbro-
matosis or musculo-aponeurotic ﬁbromatosis) are neoplasms
of ﬁbroblastic origin characterized by lack of a capsule
[1]. Desmoid tumors represent approximately 0.03% of
all tumors and 3% of soft tissues tumors [1]. They are
nonmetastatic and locally aggressive, with a high local
recurrence rate, and arise in virtually every site in the human
body [2]. Intraabdominal DTs are often observed in familial
adenomatous polyposis (FAP) and Gardner syndrome or
subsequent to localized traumatic injury (surgical or non-
surgical) [1–3]. Sporadic forms are deﬁned as nontrauma-
or nongenetic-related DTs. Isolated, sporadic, pancreatic
DTs have been considered anecdotal, with only 9 cases
described previously [4]. Here we describe the case of
patient with cystic DT; to our knowledge, the third reported
case.
2.CaseReport
A 68-year-old man presented with computerized tomogra-
phy (CT) scan results showing a 5-cm solid cystic mass in
the tail of the pancreas (Figures 1 and 2), with no signs
of vascular or visceral invasion. There was no evidence
of metastatic disease. The patient was completely asymp-
tomatic; the CT scan was performed as part of a routine
follow-up of angiographic aortic endoprosthesis placement
3 years prior for treatment of an abdominal aortic aneurysm.
In addition, the patient’s history included well-compensated
pulmonary emphysema and a pulmonary lobectomy for a
pT2N0M0 adenocarcinoma of the lung (lower left lobe) 5
years prior. There was no history of abdominal trauma or
previous abdominal surgery and no family history to suggest
genetic disease.
No clinical signs were found on physical examination.
Magnetic resonance imaging failed, owing to the generation2 Case Reports in Medicine
71.2pix Spin:0
Tilt: 8
Figure 1: Coronal CT scan showing the tumor (arrow).
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Figure 2: Assial CT scan showing the tumor (arrow).
of artifacts associated with the aortic prosthesis. Levels of
serumtumormarkers(carcinoembryonicantigen[CEA]and
CA 19.9) were in the normal range. Surgery was performed
on the suspicion of cystadenocarcinoma. During the surgical
exploration, the mass appeared to be localized completely
to the tail of the pancreas, with no invasion of adjacent
structures. There were no enlarged nodes surrounding the
tumor. A left pancreatectomy was performed with spleen
preservation and lymphadenectomy of the celiac axis and
peripancreatic nodes. The transection margin was tumor-
free. The gross appearance of the mass was of a dense grayish
tumor containing a cystic cavity, with no signs of a capsule
a n dn oe v i d e n c eo fn e c r o s i s .
Histologic sections showed proliferation of spindle-
shaped or stellate cells, with a fasciculate and storiform
growth pattern within a background of myxoid inter-
cellular matrix (Figure 3). Glassy, hyalinized, and keloid-
Figure 3: Ematossilin-eosin showing the pancreatic tissue inﬁl-
trated by the desmoid tumor.
Figure 4: In this area the tumor shows a proliferation of spindle
cells and dense collagen bundles (Ematossilin-eosin).
like collagen ﬁbers were also present focally. The cystic
area was the result of dilatation of entrapped excretory
pancreatic ducts. Immunohistochemical staining showed
cytoplasmic positivity for smooth muscle actin and focal
nuclear positivity for beta-catenin (Figure 4). Immunohis-
tochemistry for desmin, CD117 (c-kit), and CD34 was
negative, and the proliferation marker Ki67 stained 2%
of the cells. The features were those of intraabdominal
ﬁbromatosis.
The tumor inﬁltrated the pancreas and surrounding
adipose tissue. The patient developed an abscess of the
pancreatic stump, which was treated by CT-guided percuta-
neous drainage and resolved on postoperative day 28. Oral
intake was initiated on postoperative day 5, and patient was
discharged on postoperative day 16. The patient is doing well
and remained disease-free according to 60-month follow-up
CT (Figure 5).Case Reports in Medicine 3
Figure 5: Nuclear positivity sfor B-catenin.
3. Discussion
Desmoid tumors are rare, benign, soft-tissue tumors charac-
terized by ﬁbroblastic proliferation within a collagen matrix.
Recent classiﬁcation includes abdominal and nonabdomi-
nal DTs; among abdominal DTs, a further distinction is
made between abdominal-wall and intraabdominal DTs
[5]. Intraabdominal forms are infrequent, accounting for
approximately 8% of all DTs [4], and are frequently observed
in FAP and Gardner syndrome. Many reports suggest that
DTs occur in up to 32% of patients with FAP and in up to
29%ofpatientswithGardnersyndrome[1,6].Insomecases,
they arise at the site of a previous unrelated operation or
trauma and also occur rarely in association with pregnancy
[3, 7]. Sporadic intraabdominal DTs are infrequent and
appear to have a diﬀerent biological behavior and clinical
course [8]. Symptoms of DT are related to the local growth
ofthetumorandinvasionofadjacentstructures.Thepresent
patient was completely asymptomatic, with tumor discovery
upon routine CT scan for an unrelated condition.
Pancreatic DTs are extremely rare. A review of the
literature showed 9 reported cases [4, 8–14], with 2 being
cystic DT [4, 13]. Only 1 case of pancreatic DT has been
associated with a genetic disorder. Preoperative diagno-
sis of sporadic intraabdominal forms is unlikely. Some
authors advocate the use of ﬁne-needle aspiration biopsy
for superﬁcial forms [15, 16]. We decided to operate on
the suspicion of cystic pancreatic cancer; the ﬁnding of DT
was unexpected. Surgery is the treatment of choice for DTs,
and radical resection is considered curative for all cases in
which clear margins can be obtained [5, 9]. Some authors
have reported successful treatment with an extended course
of nonsteroidal anti-inﬂammatory drugs (NSAIDS) [17].
The present patient underwent left pancreatic resection with
spleen preservation. Histologically, the tumor showed the
typical appearance of intraabdominal ﬁbromatosis; the mass
was formed by slender ﬁbroblasts/myoﬁbroblasts with little
cytologic atypia and low proliferative activity, separated by
abundant collagen. The diagnosis was conﬁrmed by the
presence of cytoplasmic immunostaining for smooth muscle
actin and nuclear staining for beta-catenin, which is usually
indicative of point mutations of the Wnt gene and activation
of the Wnt signaling pathway [18].
Diagnosis of a rare case of extraintestinal gastrointestinal
stromal tumor was excluded on the bases of the morpho-
logic ﬁndings and negative immunostaining for CD34 and
CD118/c-kit. Recurrences at the site are frequent in FAP
and Gardner syndrome but appear to be absent in sporadic
pancreatic forms, according to the follow-up times reported
in the limited literature [4, 9, 10, 13–15]. The only reported
case of recurrence was in the single patient with FAP [14].
The present patient remains disease free 60 months after
surgery, consistent with previous reports.
In conclusion, sporadic pancreatic DT is an extremely
rare ﬁnding in common clinical practice. There are no
symptoms, signs, or imaging features to aid in diagnosis.
Fine-needle aspiration should be considered for incidentally
discovered small lesions. However, according to current
guidelines, surgery must be performed if there is any doubt
as to diagnosis. Follow-up is also necessary, regardless of the
low-rate of tumor recurrence.
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